Catalyst engages investor awareness firm

CardioTech International (Wilmington, Massachusetts) reported the engagement of Catalyst Financial Resources (Portland, Oregon), an investor awareness firm, to advance the awareness of CardioTech s medical device initiatives and operating performance to private and institutional investors.

We have monitored the operating progress of CardioTech for nearly a year and we believe it is on the cusp of a new era for shareholders, said Marc Robins, founder of Catalyst. We believe that CardioTech s coronary artery bypass graft represents technology that may save and change the lives of those cardiac patients having no option for traditional interventional cardiac procedures due to vasculature which is insufficient or in too poor a condition.

SpectraScience files annual report

SpectraScience (San Diego) said that it has filed an annual report covering the past three years with the Securities and Exchange Commission on Form 10-KSB. The report brings the company current with its annual filings since its re-emergence from Chapter 11 bankruptcy in August 2004.

The company is the developer of the WavStat Optical Biopsy System for use by physicians in diagnosing tissue to be normal, pre-cancerous or cancerous. The WavStat System is currently approved for use in the colon. Other applications for detecting pre-cancers in the throat are under development.